Download App
ISBN
:
9780309212212
Publisher
:
National Academies Press
Subject
:
Others
Binding
:
PAPERBACK
Pages
:
74
Year
:
2011
₹
1910.0
₹
1738.0
Buy Now
Shipping charges are applicable for books below Rs. 101.0
View Details(Imported Edition) Estimated Shipping Time : 25-28 Business Days
View DetailsDescription
Glutamate is the most pervasive neurotransmitter in the central nervous system (CNS). Despite this fact, no validated biological markers, or biomarkers, currently exist for measuring glutamate pathology in CNS disorders or injuries. Glutamate dysfunction has been associated with an extensive range of nervous system diseases and disorders. Problems with how the neurotransmitter glutamate functions in the brain have been linked to a wide variety of disorders, including schizophrenia, Alzheimer's, substance abuse, and traumatic brain injury. These conditions are widespread, affecting a large portion of the United States population, and remain difficult to treat. Efforts to understand, treat, and prevent glutamate-related disorders can be aided by the identification of valid biomarkers. The Institute of Medicine's Forum on Neuroscience and Nervous System Disorders held a workshop on June 21-22, 2010, to explore ways to accelerate the development, validation, and implementation of such biomarkers. This book investigates promising current and emerging technologies, and outlines strategies to procure resources and tools to advance drug development for associated nervous system disorders. Moreover, this report highlights presentations by expert panelists, and the open panel discussions that occurred during the workshop.
Related Items
-
of
Form and Function in the Brain and Spinal Cord: Perspectives of a Neurologist
Stephen Waxman
Starts At
2742.0
5377.0
49% OFF
The Handbook of Brain Theory and Neural Networks (A Bradford Book)
Michael A. Arbib
Starts At
1091.0
1495.0
27% OFF
Transforming the Quality of Life for People with Dementia Through Contact with the Natural World: Fresh Air on My Face
Jane Gilliard
Starts At
4718.0
5185.0
9% OFF
100 Questions & Answers About Multiple Sclerosis
William A. Sheremata
Starts At
820.0
1109.0
26% OFF
Aacn Protocols for Practice: Monitoring Neuroscience Patients
American Association of Critical-Care Nurses (AACN)
Starts At
9313.0
10235.0
9% OFF
Advancing Regulatory Science for Medical Countermeasure Development: Workshop Summary
Development
Starts At
3850.0
4231.0
9% OFF
Preparedness and Response to a Rural Mass Casualty Incident: Workshop Summary (Forum on Medical and Public Health Preparedness for a Catastrophic Events)
Forum on Medical and Public Health Preparedness for Catastrophic Events
Starts At
3352.0
3684.0
9% OFF